Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,550 | 1 | 57.5% |
| Food and Beverage | $1,886 | 24 | 42.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Viz.ai, Inc. | $3,167 | 2 | $0 (2022) |
| Medtronic, Inc. | $460.50 | 3 | $0 (2024) |
| Boston Scientific Corporation | $380.08 | 4 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $169.65 | 8 | $0 (2024) |
| Abbott Laboratories | $134.13 | 1 | $0 (2023) |
| PFIZER INC. | $65.36 | 3 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $30.61 | 2 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $29.00 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $308.12 | 7 | Medtronic, Inc. ($136.45) |
| 2023 | $548.34 | 8 | Boston Scientific Corporation ($168.96) |
| 2022 | $3,523 | 7 | Viz.ai, Inc. ($3,167) |
| 2020 | $45.10 | 2 | PFIZER INC. ($25.84) |
| 2019 | $11.35 | 1 | Janssen Pharmaceuticals, Inc ($11.35) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $32.94 | General |
| Category: Cardiovascular | ||||||
| 10/08/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $39.43 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/04/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.40 | General |
| Category: Cardiovascular | ||||||
| 09/03/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $38.35 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 04/26/2024 | Medtronic, Inc. | COBALT DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $136.45 | General |
| Category: Implantable Cardioverter Defibrillators (ICDs) | ||||||
| 03/04/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $25.02 | General |
| Category: Cardiovascular | ||||||
| 02/13/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.53 | General |
| Category: Cardiovascular | ||||||
| 12/21/2023 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $134.13 | General |
| Category: Vascular | ||||||
| 12/19/2023 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $168.96 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 12/11/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.39 | General |
| Category: Cardiovascular | ||||||
| 09/06/2023 | Medtronic, Inc. | COBALT DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $149.99 | General |
| Category: Implantable Cardioverter Defibrillators (ICDs) | ||||||
| 09/06/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/07/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.43 | General |
| Category: Cardiovascular | ||||||
| 06/14/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.12 | General |
| Category: Cardiovascular | ||||||
| 02/21/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $24.82 | General |
| 12/01/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/14/2022 | Viz.ai, Inc. | Viz.AI LVO (Device) | Consulting Fee | Cash or cash equivalent | $2,550.00 | General |
| Category: Care Coordination | ||||||
| 10/12/2022 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $174.06 | General |
| Category: Pacemakers | ||||||
| 10/06/2022 | Viz.ai, Inc. | Viz.AI LVO (Device) | Food and Beverage | Cash or cash equivalent | $616.50 | General |
| Category: Care Coordination | ||||||
| 06/29/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/04/2022 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $133.34 | General |
| Category: WATCHMAN_IC | ||||||
| 04/05/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/28/2020 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/04/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/14/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,109 | 1,423 | $560,588 | $105,278 |
| 2022 | 11 | 868 | 1,144 | $479,984 | $96,031 |
| 2021 | 9 | 808 | 1,101 | $448,121 | $106,584 |
| 2020 | 12 | 840 | 1,143 | $405,087 | $98,315 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 157 | 253 | $100,032 | $23,949 | 23.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 181 | 336 | $84,672 | $23,036 | 27.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 138 | 144 | $60,336 | $15,835 | 26.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 92 | 94 | $159,320 | $13,886 | 8.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 68 | 68 | $36,006 | $8,905 | 24.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 73 | 74 | $54,961 | $4,182 | 7.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 27 | 40 | $15,160 | $4,097 | 27.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 20 | 20 | $11,060 | $2,936 | 26.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 30 | 36 | $11,124 | $2,558 | 23.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 21 | 21 | $9,009 | $2,347 | 26.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 197 | 221 | $9,380 | $1,535 | 16.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 91 | 102 | $5,626 | $1,101 | 19.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 14 | $3,902 | $911.36 | 23.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 191 | 354 | $82,128 | $21,341 | 26.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 161 | 168 | $74,928 | $19,463 | 26.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 116 | 183 | $73,862 | $18,476 | 25.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 55 | 55 | $127,043 | $7,967 | 6.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 53 | 53 | $29,261 | $6,845 | 23.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 35 | 35 | $22,680 | $5,950 | 26.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 41 | 50 | $15,950 | $4,172 | 26.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 28 | 38 | $12,654 | $3,334 | 26.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 27 | 27 | $12,231 | $3,106 | 25.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 24 | $6,954 | $1,696 | 24.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 15 | 15 | $5,610 | $1,407 | 25.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 17 | 18 | $11,466 | $1,030 | 9.0% |
About Dr. Eli Friedman, MD
Dr. Eli Friedman, MD is a Cardiovascular Disease healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2011. The National Provider Identifier (NPI) number assigned to this provider is 1780973644.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eli Friedman, MD has received a total of $4,436 in payments from pharmaceutical and medical device companies, with $308.12 received in 2024. These payments were reported across 25 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($2,550).
As a Medicare-enrolled provider, Friedman has provided services to 3,625 Medicare beneficiaries, totaling 4,811 services with total Medicare billing of $406,209. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease
- Location Los Angeles, CA
- Active Since 03/31/2011
- Last Updated 08/29/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1780973644
Products in Payments
- Viz.AI LVO (Device) $3,167
- COBALT DR MRI SURESCAN (Device) $286.44
- WATCHMAN FLX (Device) $246.74
- MICRA (Device) $174.06
- CAMZYOS (Drug) $144.83
- MITRACLIP (Device) $134.13
- WATCHMAN Access System (Device) $133.34
- ELIQUIS (Drug) $65.36
- XARELTO (Drug) $30.61
- ENTRESTO (Drug) $29.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Los Angeles
Dr. Leslie Saxon, M.d, M.D
Cardiovascular Disease — Payments: $1.6M
Dr. Cathleen Bairey Merz, M.d, M.D
Cardiovascular Disease — Payments: $1.5M
Ramin Ebrahimi, Md, MD
Cardiovascular Disease — Payments: $879,009
Karol Watson, Md, MD
Cardiovascular Disease — Payments: $707,428
Alexander Ford, Md, MD
Cardiovascular Disease — Payments: $563,203
Rahul Doshi, M.d, M.D
Cardiovascular Disease — Payments: $479,484